JTE-907 is a selective agonist of the cannabinoid CB2 receptor, used in research to investigate anti-inflammatory and analgesic effects. It is particularly employed in studies of neuropathic pain, inflammatory pain pathways, and neuroinflammation. By activating CB2 receptors, it helps explore the role of the endocannabinoid system in modulating pain and immune responses. JTE-907 serves as a valuable tool compound for developing novel therapeutics targeting chronic pain and inflammatory conditions.